Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells

1 Feb 2022

Abstract excerpt

With the advent of novel, highly effective therapies for multiple myeloma (MM), classical serologic monitoring appears insufficient for response assessment and prediction of relapse. Moreover, serologic studies in MM are hampered by interference of therapeutic antibodies. The detection of malignant plasma cell clones by next generation sequencing (NGS) or multiparameter flow cytometry (MFC) circumvents these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Glycosylation and Glycoproteins Research
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35106639
DOI: 10.1007/s00277-022-04771-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cellsPMID 35106639Read ↗

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaSemantic proximity Read ↗

Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor DiseasesSemantic proximity Read ↗

Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple MyelomaSemantic proximity Read ↗

Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNASemantic proximity Read ↗

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.Semantic proximity Read ↗

Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myelomaSemantic proximity Read ↗

Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.Semantic proximity Read ↗

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaSemantic proximity Read ↗

Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.Semantic proximity Read ↗

Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma.Semantic proximity Read ↗

Mutational Profile and Prognostic Relevance of Circulating Tumor Cells in Multiple MyelomaSemantic proximity Read ↗

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.